共 85 条
[1]
Hundley WG(2010)ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents J Am Coll Cardiol 55 2614-2662
[2]
Bluemke DA(2013)European Cardiovascular Magnetic Resonance (EuroCMR) registry—multi national results from 57 centers in 15 countries J Cardiovasc Magn Reson 15 9-667
[3]
Finn JP(2006)Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla Invest Radiol 41 661-1131
[4]
Bruder O(2009)Intraindividual comparison of myocardial delayed enhancement MR imaging using gadobenate dimeglumine at 1.5 T and 3 T Eur Radiol 19 1124-637
[5]
Wagner A(2008)Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial Circulation 117 629-2033
[6]
Lombardi M(2006)Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement J Am Coll Cardiol 47 2027-883
[7]
Klumpp B(2007)Safety update on the possible causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis J Magn Reson Imaging 25 881-668
[8]
Fenchel M(2007)What nephrologists need to know about gadolinium Nat Clin Pract Nephrol 3 654-251
[9]
Hoevelborn T(1970)Time saving measurement of NMR and EPR relaxation times Rev Sci Instrum 41 250-156
[10]
Klumpp BD(2011)Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance JACC Cardiovasc Imaging 4 150-457